A new study at Haukeland University Hospital in Bergen, Norway, suggests that neurological side effects are among the potential problems faced by long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy.
The researchers found that between four and 21 years after the start of treatment, men who’d received any chemotherapy had a statistically significantly higher risk for more severe side effects, including sensory neuropathy, tinnitus, hearing impairment and a discoloration of the hands or feet when exposed to cold (known as Raynaud-like phenomena), than those who didn’t have chemotherapy.
According to study leader, a major aim in the treatment of testicular cancer is to minimize toxic effects without compromising the high cure rate.
The study was published online Nov. 25 in the Journal of the National Cancer Institute.
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...